Over its two editions, The New Oxford Textbook of Psychiatry has come to be regarded as one of the most popular and trusted standard psychiatry texts among psychiatrists and trainees.
John R. Geddes is Professor of Epidemiological Psychiatry and Head of the Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK. Nancy C. Andreasen is Professor of Psychiatry and Andrew H. Woods Chair of Psychiatry, Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USA. Guy M. Goodwin is Senior Research Fellow, Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
Section 1: The subject matter and approach to psychiatry; 1 Kay Redfield Jamison and Adam Ian Kaplin: The patient's perspective; 2 Nicole Votruba, Mirja Koschorke, and Graham Thornicroft: Public attitudes and the challenge of stigma; 3 Crick Lund, Dorte Bemme, and Judy Bass: Global mental health; 4 Pierre Pichot: The history of psychiatry as a medical specialty; 5 Ilina Singh, Julian Savulescu, and Matthew L. Baum: A new ethics for 21st century psychiatry; 6 Hans-Jurgen Moller: Foundations of phenomenology / descriptive psychopathology; 7 Darrel A. Regier, David P. Goldberg, Geoffrey M. Reed and Bedirhan T. Ustun: DSM-5 and ICD-11 classifications; 8 Charles A. Sanislow, Sarah E. Morris, Jennifer Pacheco, and Bruce N. Cuthbert: The National Institute of Mental Health Research Domain Criteria: An alternative framework to guide psychopathology research; 9 Andrea Cipriani, Stefan Leucht, and John R. Geddes: Application of research evidence in clinical practice; 10 Guy M. Goodwin, Joseph Zohar, and David J. Kupfer: A neuroscience based nomenclature for psychotropic drugs; Section 2: The scientific basis of psychiatric aetiology and treatment; 11 Karl Zilles and Nicola Palomero-Gallagher: Neuroanatomy; 12 Mark Woolrich, Mark Jenkinson, and Clare Mackay: Neuroimaging technologies; 13 Olaf Sporns: The connectome; 14 Trevor Sharp: Neurotransmitters and signalling; 15 Juan C. Leza, Javier R. Caso, and Borja Garcia-Bueno: Psychoneuroimmunology; 16 Caleb Webber: Functional genomics; 17 Anna Christina Nobre: Cognitive neuroscience: Principles and methods; 18 Verena Heise, Enik? Zsoldos, and Klaus P. Ebmeier: Ageing and the human brain; 19 Helen S. Mayberg, Andrea Cowell, and Patricio Riva Posse: Development of brain stimulation; 20 Amy Chan and Rob Horne: Adherence to treatment in psychiatry; Section 3: Intellectual disabilities; 21 Anthony J. Holland: Core dimensions of intellectual disabilities; 22 Sally-Ann Cooper: Epidemiology and course of intellectual disabilities; 23 Judith L. Rapoport, Dale Zhou, and Kwangmi Ahn: Aetiology of intellectual disability: General issues and prevention; 24 Jose-Luis Ayuso-Mateos and Cary S. Kogan: Management and treatment of intellectual disability; Section 4: Autism spectrum disorders; 25 Fred R. Volkmar and Scott L. J. Jackson: Core dimensions of autism spectrum disorders; 26 Emily J. H. Jones: Basic mechanisms and treatment targets for autism spectrum disorders; 27 Charles R. Newton: Epidemiology of autism; 28 Abha R. Gupta, Thomas V. Fernandez, and Ellen J. Hoffman: Genetics of autism spectrum disorders; 29 Christine Eckera and Declan Murphy: Imaging of autism spectrum disorders; 30 Emily Simonoff: Management and treatment of autism spectrum disorders; Section 5: Attention deficit and hyperactivity disorder; 31 Eric Taylor: Core dimensions of attention deficit hyperactivity disorder; 32 Barbara Franke and Jan K. Buitelaar: Basic mechanisms and treatment planning / targets for attention deficit hyperactivity disorder; 33 Guilherme V. Polanczyk: Epidemiology of attention deficit hyperactivity disorder and the implications for its prevention; 34 Kate Langley and Anita Thapar: Genetics of attention deficit hyperactivity disorder; 35 Philip Shaw and Eszter Szekely: Insights from neuroanatomical imaging into attention deficit hyperactivity disorder throughout the lifespan; 36 Alessandro Zuddas and Sara Carucci: Management and treatment of attention deficit hyperactivity disorder; Section 6: Motor disorders; 37 Davide Martino and Antonella Macerollo: Neurodevelopmental motor disorders; Section 7: Delirium, dementia, and other cognitive disorders; 38 Noel J. Buckley and George K. Tofaris: Pathways of neurodegeneration underlying dementia; 39 Ravi S. Bhat and Kenneth Rockwood: Delirium; 40 Ivan Koychev and John Gallacher: Alzheimer's disease; 41 Akitoshi Takeda and Bruce Miller: Frontotemporal dementias; 42 Akin Nihat, TzeHow Mok, and John Collinge: Prion disease; 43 Anto P. Rajkumar and Dag Aarsland: Dementia with Lewy bodies; 44 Michele Hu and Fahd Baig: Dementia in Parkinson's disease; 45 Russell L. Margolis: Dementia due to Huntington's disease; 46 Joanne A. Byars and Ricardo E. Jorge: Vascular cognitive impairment; 47 Christian Lepage, Inga K. Koerte, Vivian Schultz, Michael J. Coleman, and Martha E. Shenton: Traumatic brain injury; Section 8: Substance use disorders; 48 Trevor W. Robbins and Barry J. Everitt: Substance use disorders and the mechanisms of drug addiction; 49 Yann Le Strat, Nicolas Ramoz, and Philip Gorwood: Genetics of substance use disorders; 50 Wim van den Brink and Falk Kiefer: Alcohol use disorder; 51 Michael Farrell, Briony Larance, and Courtney Breen: Opiates: Heroin, methadone, buprenorphine; 52 David J. Castle: Cannabis and mental illness; 53 Adam R. Winstock and Remy Flechais: Stimulants, ecstasy, and other party drugs; 54 Adam Winstock and James Rucker: Psychedelics and dissociative substances; 55 Marcus Munafo and Meryem Grabski: Tobacco addiction; 56 Julia M. A. Sinclair and Anne Lingford-Hughes: Co-morbidity of substance use and psychiatric disorders; Section 9: Schizophrenia and psychotic disorders; 57 Nancy C. Andreasen: The core dimensions of schizophrenia; 58 Assen Jablensky: Epidemiology and course of schizophrenia; 59 Kimberley M. Kendall, James T. R. Walters and Michael C. O Donovan: Genetics of schizophrenia; 60 Andreea O. Diaconescu, Sandra Iglesias, and Klaas E. Stephan: Structural and functional neuroimaging of schizophrenia; 61 William S. Stone, Stephen V. Faraone and Ming T. Tsuang: Schizoaffective and schizotypal disorders / acute and transient psychotic disorders; 62 Andreas Marneros: Delusional disorders; 63 Emre Bora, Mahesh Jayaram, and Christos Pantelis: Prevention and early intervention in psychotic disorders; 64 Herbert Y. Meltzer and William V. Bobo: Antipsychotic and anticholinergic drugs; 65 Joseph P. McEvoy, Kammarauche Asuzu, Daniel W. Bradford, Oliver Freudenreich, and Katherine Moyer: The treatment and management of patients with schizophrenia; Section 10: Mood disorders; 66 S. Nassir Ghaemi and Sivan Mauer: Diagnosis, classification and differential diagnosis of mood disorders; 67 Lars Vedel Kessing: Epidemiology of mood disorders; 68 Gin S. Malhi: Primary prevention of mood disorders: Building a target for prevention strategies; Section 11: Bipolar disorder; 69 Grant C. Churchill, Nisha Singh, and Michael J. Berridge: Basic mechanisms of and treatment targets for bipolar disorder; 70 Francis J. MacMahon and Sevilla Detera-Wadlieigh: Genetics of bipolar disorder; 71 Mary L. Phillips and Wayne C. Drevets: Neuroimaging of bipolar disorder; 72 Eduard Vieta, Isabella Pacchiarotti, and David J. Miklowitz: Management and treatment of bipolar disorder; 73 Ian Jones and Arianna Di Florio: Perinatal psychiatry; Section 12: Depressive disorders; 74 Marcela Pereira, Roberto Andreatini, and Per Svenningsson: Basic mechanisms of and treatment targets for depressive disorders; 75 Alison K. Merikangas and Kathleen R. Merikangas: Genetic epidemiology of depression in the molecular era; 76 Guy M. Goodwin and Michael Browning: Imaging of depressive disorders; 77 Philip J. Cowen: Management and treatment of depressive disorders; Section 13: Trauma and stress or related and adjustment disorders; 78 Dean G. Kilpatrick, Matthew J. Friedman, and Amanda K. Gilmore: Classification and descriptive psychopathology of posttraumatic stress disorder and other stressor-related disorders; 79 Bruce S. McEwen: Basic mechanisms of and treatment targets for stress-related disorders; 80 Michael G. Gottschalk and Katharina Domschke: Genetics of stress-related disorders; 81 Navneet Kaur, Cecilia Hinojosa, Julia Russell, Michael B. Van Elzakker, and Lisa M. Shin: Imaging of stress-related disorders; 82 Maria Bragesjo, Emily A. Holmes, Filip Arnberg, and Erik M. Andersson: Primary prevention and epidemiology of trauma and stress related disorders; 83 Leigh van den Heuvel and Soraya Seedat: Management and treatment of stress-related disorders; 84 Beverley Raphael, Sally Wooding, and Julie Dunsmore: Bereavement; 85 Deborah Davis and Elizabeth F. Loftus: Recovered memories and false memories; Section 14: Anxiety disorders; 86 Nastassja Koen and Dan J. Stein: Core dimensions of anxiety disorders; 87 Martien Kas and Berend Olivier: Basic mechanisms, genetics, targets and animal models for anxiety disorders; 88 Hans-Ulrich Wittchen and Katja Beesdo-Baum: Epidemiology and course of anxiety disorders; 89 Michael G. Gottschalk and Katharina Domschke: Genetics of anxiety disorders; 90 Gregor Leicht and Christoph Mulert: Neuroimaging of anxiety disorders; 91 Aliza Werner-Seidler, Jennifer L. Hudson, and Helen Christensen: The primary prevention of anxiety disorders; 92 David S. Baldwin and Nathan T. M. Huneke: Treatment of anxiety disorders; Section 15: Obsessive-compulsive and related disorders; 93 Sophie C. Snyder, Eric A. Storch, and Wayne K. Goodman: Core dimensions of obsessive-compulsive disorder; 94 Eric Burguiere and Luc Mallet: Basic mechanisms of and treatment / planning targets for obsessive-complusive disorder; 95 Lior Carmi, Naomi A. Fineberg, Oded Ben-Arush, and Joseph Zohar: Obsessive-compulsive disorder; 96 Gerald Nestadt and Jack Samuels: Genetics of obsessive-compulsive disorder; 97 Rebbia Shahab and Emily R. Stern: Imaging of obsessive-compulsive disorder; 98 Naomi A. Fineberg, Lynne M. Drummond, Jemma Reid, Eduardo Cinosi, Lior Carmi, and Davis N. Mpavaenda: Management and treatment of obsessive-compulsive disorder; 99 Lorena Fernandez de la Cruz and David Mataix-Cols: Hoarding disorder; 100 Megan M. Kelly and Katharine A. Phillips: Body dysmorphic disorder; Section 16: Feeding and eating disorders; 101 Chris Fairburn and Rebecca Murphy: The eating disorders; 102 Johannes Hebebrand, Jochen Antel, and Beate Herpertz-Dahlmann: Basic mechanisms and potential for treatment of weight and eating disorders; 103 Katherine A Halmi: Epidemiology and primary prevention of feeding and eating disorders; 104 Christopher Huble, Cynthia Bulik, and Gerome Breen: Genetics of feeding and eating disorders; 105 Natalie Kurniadi, Christina E. Wierenga, Laura A. Berner, and Walter H. Kaye: Imaging of feeding and eating disorders; 106 Susan L. McElroy, Anna I. Guerdjikova, Nicole Mori, Paul L. Houser, and Paul E. Keck, Jr.: Management and treatment of feeding and eating disorders; 107 Jamie Hartmann-Boyce, Nerys M. Astbury, and Susan A. Jebb: Aetiology and management of obesity; 108 Alexander von Gontard: Elimination disorders in children and adolescents; Section 17: Sleep wake disorders; 109 David Pritchett, Angus S. Fisk, Russell G. Foster, and Stuart N. Peirson: Basic mechanisms of and treatment targets for sleep-wake disorders; 110 Kirstie Anderson: Diagnosis of sleep and circadian rhythm disorder; 111 Lena Katharina Keller, Eva C. Winnebeck, and Till Roenneberg: Epidemiology of sleep-wake and primary prevention of its disorders; 112 Diego R. Mazzotti, Allan I. Pack, and Philip R. Gehrman: Genetics of sleep-wake disorders; 113 Umberto Moretto, Dylan Smith, Liliana Dell Osso, and Thien Thanh Dang-Vu: Multi-modal imaging of sleep-wake disorders; 114 Simon D. Kyle, Alasdair L. Henry, and Colin A. Espie: Management of insomnia and circadian rhythm sleep-wake disorders; Section 18: Sexual function and sexual dysfunction; 115 Cynthia A. Graham and John Bancroft: The sexual dysfunctions and paraphilias; 116 Els Elaut and Gunter Heylens: Gender dysphoria; Section 19: Personality disorders; 117 Andrew E. Skodol and Leslie C. Morey: Core dimensions of personality pathology; 118 Kate E. A. Saunders and Steve Pearce: Basic mechanisms of and treatment planning / targets for personality disorders; 119 Renato D. Alarcon and Brian A. Palmer: Personality disorders: Epidemiology and clinical course; 120 C. Robert Cloninger: Genetics of personality disorders; 121 Christian Paret and Christian Schmahl: Imaging of personality disorders; 122 Giles Newton-Howes and Roger Mulder: Treatment and management of personality disorder; Section 20: Impulse control and conduct disorders; 123 Donald W. Black: Impulse control and its disorders: including pathological gambling; 124 Stephen Scott and Melanie Palmer: Conduct disorders and antisocial personality disorder in childhood and adolescence; Section 21: Suicide; 125 Merete Nordentoft, Trine Madsen, and Annette Erlangsen: Epidemiology and causes of suicide; 126 Nav Kapur, Sarah Steeg, and Adam Moreton: Self-harm: Epidemiology and risk factors; 127 J. John Mann and Dianne Currier: Biological aspects of suicidal behaviour; 128 Keith Hawton, Kate E. A. Saunders, and Alexandra Pitman: Prevention of suicide and treatment following self-harm; Section 22: Somatic symptoms and related disorders; 129 Michael Sharpe and Jane Walker: Deconstructing dualism: The interface between physical and psychological illness; 130 Chantal Berna and Irene Tracey: Neural mechanisms in chronic pain relevant for psychiatric interventions; 131 Jonathan Price: Treatment of fibromyalgia (chronic widespread pain) and chronic fatigue syndrome; 132 Thomas Merten and Harald Merckelbach: Factitious disorder and malingering; 133 Jon Stone and Michael Sharpe: Functional neurological symptom disorder (Conversion disorder); Section 23: Service provision; 134 Martin Knapp: Public policy and service needs in mental health; 135 Tom Burns and Tony Kendrick: Planning and providing mental health services for a community; 136 Judit Simon: Health economic analysis of service provision; 137 William H. Sledge and Julianne Dorset: The organization of psychiatric services for general hospital departments: Proactive and preventive interventions in psychiatry; 138 Mina Fazel, Susan Rees, and Derrick Silove: Refugees and populations exposed to mass conflict; Section 24: Forensic psychiatry; 139 Seena Fazel and Mark Toynbee: Associations between psychiatric disorder and offending; 140 Sue Bailey and Prathiba Chitsabesan: Developmental approach to understanding the needs of young people in contact with the criminal justice system; 141 Stephen J. Hucker: Child molesters and other sexual offenders; 142 Rosemary Purcell and Paul E. Mullen: Stalking and querulous behaviour; 143 Louise M. Howard and Deirdre MacManus: Domestic violence and abuse and mental health; 144 Alec Buchanan: Assessing and managing the risk of violence towards others; 145 John O Grady: The expert witness in the criminal and civil courts; 146 Matthew Large and Olav Nielssen: Homicide
Show moreOver its two editions, The New Oxford Textbook of Psychiatry has come to be regarded as one of the most popular and trusted standard psychiatry texts among psychiatrists and trainees.
John R. Geddes is Professor of Epidemiological Psychiatry and Head of the Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK. Nancy C. Andreasen is Professor of Psychiatry and Andrew H. Woods Chair of Psychiatry, Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USA. Guy M. Goodwin is Senior Research Fellow, Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
Section 1: The subject matter and approach to psychiatry; 1 Kay Redfield Jamison and Adam Ian Kaplin: The patient's perspective; 2 Nicole Votruba, Mirja Koschorke, and Graham Thornicroft: Public attitudes and the challenge of stigma; 3 Crick Lund, Dorte Bemme, and Judy Bass: Global mental health; 4 Pierre Pichot: The history of psychiatry as a medical specialty; 5 Ilina Singh, Julian Savulescu, and Matthew L. Baum: A new ethics for 21st century psychiatry; 6 Hans-Jurgen Moller: Foundations of phenomenology / descriptive psychopathology; 7 Darrel A. Regier, David P. Goldberg, Geoffrey M. Reed and Bedirhan T. Ustun: DSM-5 and ICD-11 classifications; 8 Charles A. Sanislow, Sarah E. Morris, Jennifer Pacheco, and Bruce N. Cuthbert: The National Institute of Mental Health Research Domain Criteria: An alternative framework to guide psychopathology research; 9 Andrea Cipriani, Stefan Leucht, and John R. Geddes: Application of research evidence in clinical practice; 10 Guy M. Goodwin, Joseph Zohar, and David J. Kupfer: A neuroscience based nomenclature for psychotropic drugs; Section 2: The scientific basis of psychiatric aetiology and treatment; 11 Karl Zilles and Nicola Palomero-Gallagher: Neuroanatomy; 12 Mark Woolrich, Mark Jenkinson, and Clare Mackay: Neuroimaging technologies; 13 Olaf Sporns: The connectome; 14 Trevor Sharp: Neurotransmitters and signalling; 15 Juan C. Leza, Javier R. Caso, and Borja Garcia-Bueno: Psychoneuroimmunology; 16 Caleb Webber: Functional genomics; 17 Anna Christina Nobre: Cognitive neuroscience: Principles and methods; 18 Verena Heise, Enik? Zsoldos, and Klaus P. Ebmeier: Ageing and the human brain; 19 Helen S. Mayberg, Andrea Cowell, and Patricio Riva Posse: Development of brain stimulation; 20 Amy Chan and Rob Horne: Adherence to treatment in psychiatry; Section 3: Intellectual disabilities; 21 Anthony J. Holland: Core dimensions of intellectual disabilities; 22 Sally-Ann Cooper: Epidemiology and course of intellectual disabilities; 23 Judith L. Rapoport, Dale Zhou, and Kwangmi Ahn: Aetiology of intellectual disability: General issues and prevention; 24 Jose-Luis Ayuso-Mateos and Cary S. Kogan: Management and treatment of intellectual disability; Section 4: Autism spectrum disorders; 25 Fred R. Volkmar and Scott L. J. Jackson: Core dimensions of autism spectrum disorders; 26 Emily J. H. Jones: Basic mechanisms and treatment targets for autism spectrum disorders; 27 Charles R. Newton: Epidemiology of autism; 28 Abha R. Gupta, Thomas V. Fernandez, and Ellen J. Hoffman: Genetics of autism spectrum disorders; 29 Christine Eckera and Declan Murphy: Imaging of autism spectrum disorders; 30 Emily Simonoff: Management and treatment of autism spectrum disorders; Section 5: Attention deficit and hyperactivity disorder; 31 Eric Taylor: Core dimensions of attention deficit hyperactivity disorder; 32 Barbara Franke and Jan K. Buitelaar: Basic mechanisms and treatment planning / targets for attention deficit hyperactivity disorder; 33 Guilherme V. Polanczyk: Epidemiology of attention deficit hyperactivity disorder and the implications for its prevention; 34 Kate Langley and Anita Thapar: Genetics of attention deficit hyperactivity disorder; 35 Philip Shaw and Eszter Szekely: Insights from neuroanatomical imaging into attention deficit hyperactivity disorder throughout the lifespan; 36 Alessandro Zuddas and Sara Carucci: Management and treatment of attention deficit hyperactivity disorder; Section 6: Motor disorders; 37 Davide Martino and Antonella Macerollo: Neurodevelopmental motor disorders; Section 7: Delirium, dementia, and other cognitive disorders; 38 Noel J. Buckley and George K. Tofaris: Pathways of neurodegeneration underlying dementia; 39 Ravi S. Bhat and Kenneth Rockwood: Delirium; 40 Ivan Koychev and John Gallacher: Alzheimer's disease; 41 Akitoshi Takeda and Bruce Miller: Frontotemporal dementias; 42 Akin Nihat, TzeHow Mok, and John Collinge: Prion disease; 43 Anto P. Rajkumar and Dag Aarsland: Dementia with Lewy bodies; 44 Michele Hu and Fahd Baig: Dementia in Parkinson's disease; 45 Russell L. Margolis: Dementia due to Huntington's disease; 46 Joanne A. Byars and Ricardo E. Jorge: Vascular cognitive impairment; 47 Christian Lepage, Inga K. Koerte, Vivian Schultz, Michael J. Coleman, and Martha E. Shenton: Traumatic brain injury; Section 8: Substance use disorders; 48 Trevor W. Robbins and Barry J. Everitt: Substance use disorders and the mechanisms of drug addiction; 49 Yann Le Strat, Nicolas Ramoz, and Philip Gorwood: Genetics of substance use disorders; 50 Wim van den Brink and Falk Kiefer: Alcohol use disorder; 51 Michael Farrell, Briony Larance, and Courtney Breen: Opiates: Heroin, methadone, buprenorphine; 52 David J. Castle: Cannabis and mental illness; 53 Adam R. Winstock and Remy Flechais: Stimulants, ecstasy, and other party drugs; 54 Adam Winstock and James Rucker: Psychedelics and dissociative substances; 55 Marcus Munafo and Meryem Grabski: Tobacco addiction; 56 Julia M. A. Sinclair and Anne Lingford-Hughes: Co-morbidity of substance use and psychiatric disorders; Section 9: Schizophrenia and psychotic disorders; 57 Nancy C. Andreasen: The core dimensions of schizophrenia; 58 Assen Jablensky: Epidemiology and course of schizophrenia; 59 Kimberley M. Kendall, James T. R. Walters and Michael C. O Donovan: Genetics of schizophrenia; 60 Andreea O. Diaconescu, Sandra Iglesias, and Klaas E. Stephan: Structural and functional neuroimaging of schizophrenia; 61 William S. Stone, Stephen V. Faraone and Ming T. Tsuang: Schizoaffective and schizotypal disorders / acute and transient psychotic disorders; 62 Andreas Marneros: Delusional disorders; 63 Emre Bora, Mahesh Jayaram, and Christos Pantelis: Prevention and early intervention in psychotic disorders; 64 Herbert Y. Meltzer and William V. Bobo: Antipsychotic and anticholinergic drugs; 65 Joseph P. McEvoy, Kammarauche Asuzu, Daniel W. Bradford, Oliver Freudenreich, and Katherine Moyer: The treatment and management of patients with schizophrenia; Section 10: Mood disorders; 66 S. Nassir Ghaemi and Sivan Mauer: Diagnosis, classification and differential diagnosis of mood disorders; 67 Lars Vedel Kessing: Epidemiology of mood disorders; 68 Gin S. Malhi: Primary prevention of mood disorders: Building a target for prevention strategies; Section 11: Bipolar disorder; 69 Grant C. Churchill, Nisha Singh, and Michael J. Berridge: Basic mechanisms of and treatment targets for bipolar disorder; 70 Francis J. MacMahon and Sevilla Detera-Wadlieigh: Genetics of bipolar disorder; 71 Mary L. Phillips and Wayne C. Drevets: Neuroimaging of bipolar disorder; 72 Eduard Vieta, Isabella Pacchiarotti, and David J. Miklowitz: Management and treatment of bipolar disorder; 73 Ian Jones and Arianna Di Florio: Perinatal psychiatry; Section 12: Depressive disorders; 74 Marcela Pereira, Roberto Andreatini, and Per Svenningsson: Basic mechanisms of and treatment targets for depressive disorders; 75 Alison K. Merikangas and Kathleen R. Merikangas: Genetic epidemiology of depression in the molecular era; 76 Guy M. Goodwin and Michael Browning: Imaging of depressive disorders; 77 Philip J. Cowen: Management and treatment of depressive disorders; Section 13: Trauma and stress or related and adjustment disorders; 78 Dean G. Kilpatrick, Matthew J. Friedman, and Amanda K. Gilmore: Classification and descriptive psychopathology of posttraumatic stress disorder and other stressor-related disorders; 79 Bruce S. McEwen: Basic mechanisms of and treatment targets for stress-related disorders; 80 Michael G. Gottschalk and Katharina Domschke: Genetics of stress-related disorders; 81 Navneet Kaur, Cecilia Hinojosa, Julia Russell, Michael B. Van Elzakker, and Lisa M. Shin: Imaging of stress-related disorders; 82 Maria Bragesjo, Emily A. Holmes, Filip Arnberg, and Erik M. Andersson: Primary prevention and epidemiology of trauma and stress related disorders; 83 Leigh van den Heuvel and Soraya Seedat: Management and treatment of stress-related disorders; 84 Beverley Raphael, Sally Wooding, and Julie Dunsmore: Bereavement; 85 Deborah Davis and Elizabeth F. Loftus: Recovered memories and false memories; Section 14: Anxiety disorders; 86 Nastassja Koen and Dan J. Stein: Core dimensions of anxiety disorders; 87 Martien Kas and Berend Olivier: Basic mechanisms, genetics, targets and animal models for anxiety disorders; 88 Hans-Ulrich Wittchen and Katja Beesdo-Baum: Epidemiology and course of anxiety disorders; 89 Michael G. Gottschalk and Katharina Domschke: Genetics of anxiety disorders; 90 Gregor Leicht and Christoph Mulert: Neuroimaging of anxiety disorders; 91 Aliza Werner-Seidler, Jennifer L. Hudson, and Helen Christensen: The primary prevention of anxiety disorders; 92 David S. Baldwin and Nathan T. M. Huneke: Treatment of anxiety disorders; Section 15: Obsessive-compulsive and related disorders; 93 Sophie C. Snyder, Eric A. Storch, and Wayne K. Goodman: Core dimensions of obsessive-compulsive disorder; 94 Eric Burguiere and Luc Mallet: Basic mechanisms of and treatment / planning targets for obsessive-complusive disorder; 95 Lior Carmi, Naomi A. Fineberg, Oded Ben-Arush, and Joseph Zohar: Obsessive-compulsive disorder; 96 Gerald Nestadt and Jack Samuels: Genetics of obsessive-compulsive disorder; 97 Rebbia Shahab and Emily R. Stern: Imaging of obsessive-compulsive disorder; 98 Naomi A. Fineberg, Lynne M. Drummond, Jemma Reid, Eduardo Cinosi, Lior Carmi, and Davis N. Mpavaenda: Management and treatment of obsessive-compulsive disorder; 99 Lorena Fernandez de la Cruz and David Mataix-Cols: Hoarding disorder; 100 Megan M. Kelly and Katharine A. Phillips: Body dysmorphic disorder; Section 16: Feeding and eating disorders; 101 Chris Fairburn and Rebecca Murphy: The eating disorders; 102 Johannes Hebebrand, Jochen Antel, and Beate Herpertz-Dahlmann: Basic mechanisms and potential for treatment of weight and eating disorders; 103 Katherine A Halmi: Epidemiology and primary prevention of feeding and eating disorders; 104 Christopher Huble, Cynthia Bulik, and Gerome Breen: Genetics of feeding and eating disorders; 105 Natalie Kurniadi, Christina E. Wierenga, Laura A. Berner, and Walter H. Kaye: Imaging of feeding and eating disorders; 106 Susan L. McElroy, Anna I. Guerdjikova, Nicole Mori, Paul L. Houser, and Paul E. Keck, Jr.: Management and treatment of feeding and eating disorders; 107 Jamie Hartmann-Boyce, Nerys M. Astbury, and Susan A. Jebb: Aetiology and management of obesity; 108 Alexander von Gontard: Elimination disorders in children and adolescents; Section 17: Sleep wake disorders; 109 David Pritchett, Angus S. Fisk, Russell G. Foster, and Stuart N. Peirson: Basic mechanisms of and treatment targets for sleep-wake disorders; 110 Kirstie Anderson: Diagnosis of sleep and circadian rhythm disorder; 111 Lena Katharina Keller, Eva C. Winnebeck, and Till Roenneberg: Epidemiology of sleep-wake and primary prevention of its disorders; 112 Diego R. Mazzotti, Allan I. Pack, and Philip R. Gehrman: Genetics of sleep-wake disorders; 113 Umberto Moretto, Dylan Smith, Liliana Dell Osso, and Thien Thanh Dang-Vu: Multi-modal imaging of sleep-wake disorders; 114 Simon D. Kyle, Alasdair L. Henry, and Colin A. Espie: Management of insomnia and circadian rhythm sleep-wake disorders; Section 18: Sexual function and sexual dysfunction; 115 Cynthia A. Graham and John Bancroft: The sexual dysfunctions and paraphilias; 116 Els Elaut and Gunter Heylens: Gender dysphoria; Section 19: Personality disorders; 117 Andrew E. Skodol and Leslie C. Morey: Core dimensions of personality pathology; 118 Kate E. A. Saunders and Steve Pearce: Basic mechanisms of and treatment planning / targets for personality disorders; 119 Renato D. Alarcon and Brian A. Palmer: Personality disorders: Epidemiology and clinical course; 120 C. Robert Cloninger: Genetics of personality disorders; 121 Christian Paret and Christian Schmahl: Imaging of personality disorders; 122 Giles Newton-Howes and Roger Mulder: Treatment and management of personality disorder; Section 20: Impulse control and conduct disorders; 123 Donald W. Black: Impulse control and its disorders: including pathological gambling; 124 Stephen Scott and Melanie Palmer: Conduct disorders and antisocial personality disorder in childhood and adolescence; Section 21: Suicide; 125 Merete Nordentoft, Trine Madsen, and Annette Erlangsen: Epidemiology and causes of suicide; 126 Nav Kapur, Sarah Steeg, and Adam Moreton: Self-harm: Epidemiology and risk factors; 127 J. John Mann and Dianne Currier: Biological aspects of suicidal behaviour; 128 Keith Hawton, Kate E. A. Saunders, and Alexandra Pitman: Prevention of suicide and treatment following self-harm; Section 22: Somatic symptoms and related disorders; 129 Michael Sharpe and Jane Walker: Deconstructing dualism: The interface between physical and psychological illness; 130 Chantal Berna and Irene Tracey: Neural mechanisms in chronic pain relevant for psychiatric interventions; 131 Jonathan Price: Treatment of fibromyalgia (chronic widespread pain) and chronic fatigue syndrome; 132 Thomas Merten and Harald Merckelbach: Factitious disorder and malingering; 133 Jon Stone and Michael Sharpe: Functional neurological symptom disorder (Conversion disorder); Section 23: Service provision; 134 Martin Knapp: Public policy and service needs in mental health; 135 Tom Burns and Tony Kendrick: Planning and providing mental health services for a community; 136 Judit Simon: Health economic analysis of service provision; 137 William H. Sledge and Julianne Dorset: The organization of psychiatric services for general hospital departments: Proactive and preventive interventions in psychiatry; 138 Mina Fazel, Susan Rees, and Derrick Silove: Refugees and populations exposed to mass conflict; Section 24: Forensic psychiatry; 139 Seena Fazel and Mark Toynbee: Associations between psychiatric disorder and offending; 140 Sue Bailey and Prathiba Chitsabesan: Developmental approach to understanding the needs of young people in contact with the criminal justice system; 141 Stephen J. Hucker: Child molesters and other sexual offenders; 142 Rosemary Purcell and Paul E. Mullen: Stalking and querulous behaviour; 143 Louise M. Howard and Deirdre MacManus: Domestic violence and abuse and mental health; 144 Alec Buchanan: Assessing and managing the risk of violence towards others; 145 John O Grady: The expert witness in the criminal and civil courts; 146 Matthew Large and Olav Nielssen: Homicide
Show moreSection 1: The subject matter and approach to psychiatry
1: Kay Redfield Jamison and Adam Ian Kaplin: The patient's
perspective
2: Nicole Votruba, Mirja Koschorke, and Graham Thornicroft: Public
attitudes and the challenge of stigma
3: Crick Lund, Dörte Bemme, and Judy Bass: Global mental health
4: Pierre Pichot: The history of psychiatry as a medical
specialty
5: Ilina Singh, Julian Savulescu, and Matthew L. Baum: A new ethics
for 21st century psychiatry
6: Hans-Jürgen Möller: Foundations of phenomenology / descriptive
psychopathology
7: Darrel A. Regier, David P. Goldberg, Geoffrey M. Reed and
Bedirhan T. Ustun: DSM-5 and ICD-11 classifications
8: Charles A. Sanislow, Sarah E. Morris, Jennifer Pacheco, and
Bruce N. Cuthbert: The National Institute of Mental Health Research
Domain Criteria: An alternative framework to guide psychopathology
research
9: Andrea Cipriani, Stefan Leucht, and John R. Geddes: Application
of research evidence in clinical practice
10: Guy M. Goodwin, Joseph Zohar, and David J. Kupfer: A
neuroscience based nomenclature for psychotropic drugs
Section 2: The scientific basis of psychiatric aetiology and
treatment
11: Karl Zilles and Nicola Palomero-Gallagher: Neuroanatomy
12: Mark Woolrich, Mark Jenkinson, and Clare Mackay: Neuroimaging
technologies
13: Olaf Sporns: The connectome
14: Trevor Sharp: Neurotransmitters and signalling
15: Juan C. Leza, Javier R. Caso, and Borja García-Bueno:
Psychoneuroimmunology
16: Caleb Webber: Functional genomics
17: Anna Christina Nobre: Cognitive neuroscience: Principles and
methods
18: Verena Heise, Enik? Zsoldos, and Klaus P. Ebmeier: Ageing and
the human brain
19: Helen S. Mayberg, Andrea Cowell, and Patricio Riva Posse:
Development of brain stimulation
20: Amy Chan and Rob Horne: Adherence to treatment in
psychiatry
Section 3: Intellectual disabilities
21: Anthony J. Holland: Core dimensions of intellectual
disabilities
22: Sally-Ann Cooper: Epidemiology and course of intellectual
disabilities
23: Judith L. Rapoport, Dale Zhou, and Kwangmi Ahn: Aetiology of
intellectual disability: General issues and prevention
24: José-Luis Ayuso-Mateos and Cary S. Kogan: Management and
treatment of intellectual disability
Section 4: Autism spectrum disorders
25: Fred R. Volkmar and Scott L. J. Jackson: Core dimensions of
autism spectrum disorders
26: Emily J. H. Jones: Basic mechanisms and treatment targets for
autism spectrum disorders
27: Charles R. Newton: Epidemiology of autism
28: Abha R. Gupta, Thomas V. Fernandez, and Ellen J. Hoffman:
Genetics of autism spectrum disorders
29: Christine Eckera and Declan Murphy: Imaging of autism spectrum
disorders
30: Emily Simonoff: Management and treatment of autism spectrum
disorders
Section 5: Attention deficit and hyperactivity disorder
31: Eric Taylor: Core dimensions of attention deficit hyperactivity
disorder
32: Barbara Franke and Jan K. Buitelaar: Basic mechanisms and
treatment planning / targets for attention deficit hyperactivity
disorder
33: Guilherme V. Polanczyk: Epidemiology of attention deficit
hyperactivity disorder and the implications for its prevention
34: Kate Langley and Anita Thapar: Genetics of attention deficit
hyperactivity disorder
35: Philip Shaw and Eszter Szekely: Insights from neuroanatomical
imaging into attention deficit hyperactivity disorder throughout
the lifespan
36: Alessandro Zuddas and Sara Carucci: Management and treatment of
attention deficit hyperactivity disorder
Section 6: Motor disorders
37: Davide Martino and Antonella Macerollo: Neurodevelopmental
motor disorders
Section 7: Delirium, dementia, and other cognitive disorders
38: Noel J. Buckley and George K. Tofaris: Pathways of
neurodegeneration underlying dementia
39: Ravi S. Bhat and Kenneth Rockwood: Delirium
40: Ivan Koychev and John Gallacher: Alzheimer's disease
41: Akitoshi Takeda and Bruce Miller: Frontotemporal dementias
42: Akin Nihat, TzeHow Mok, and John Collinge: Prion disease
43: Anto P. Rajkumar and Dag Aarsland: Dementia with Lewy
bodies
44: Michele Hu and Fahd Baig: Dementia in Parkinson's disease
45: Russell L. Margolis: Dementia due to Huntington's disease
46: Joanne A. Byars and Ricardo E. Jorge: Vascular cognitive
impairment
47: Christian Lepage, Inga K. Koerte, Vivian Schultz, Michael J.
Coleman, and Martha E. Shenton: Traumatic brain injury
Section 8: Substance use disorders
48: Trevor W. Robbins and Barry J. Everitt: Substance use disorders
and the mechanisms of drug addiction
49: Yann Le Strat, Nicolas Ramoz, and Philip Gorwood: Genetics of
substance use disorders
50: Wim van den Brink and Falk Kiefer: Alcohol use disorder
51: Michael Farrell, Briony Larance, and Courtney Breen: Opiates:
Heroin, methadone, buprenorphine
52: David J. Castle: Cannabis and mental illness
53: Adam R. Winstock and Remy Flechais: Stimulants, ecstasy, and
other party drugs
54: Adam Winstock and James Rucker: Psychedelics and dissociative
substances
55: Marcus Munafo and Meryem Grabski: Tobacco addiction
56: Julia M. A. Sinclair and Anne Lingford-Hughes: Co-morbidity of
substance use and psychiatric disorders
Section 9: Schizophrenia and psychotic disorders
57: Nancy C. Andreasen: The core dimensions of schizophrenia
58: Assen Jablensky: Epidemiology and course of schizophrenia
59: Kimberley M. Kendall, James T. R. Walters and Michael C. O
Donovan: Genetics of schizophrenia
60: Andreea O. Diaconescu, Sandra Iglesias, and Klaas E. Stephan:
Structural and functional neuroimaging of schizophrenia
61: William S. Stone, Stephen V. Faraone and Ming T. Tsuang:
Schizoaffective and schizotypal disorders / acute and transient
psychotic disorders
62: Andreas Marneros: Delusional disorders
63: Emre Bora, Mahesh Jayaram, and Christos Pantelis: Prevention
and early intervention in psychotic disorders
64: Herbert Y. Meltzer and William V. Bobo: Antipsychotic and
anticholinergic drugs
65: Joseph P. McEvoy, Kammarauche Asuzu, Daniel W. Bradford, Oliver
Freudenreich, and Katherine Moyer: The treatment and management of
patients with schizophrenia
Section 10: Mood disorders
66: S. Nassir Ghaemi and Sivan Mauer: Diagnosis, classification and
differential diagnosis of mood disorders
67: Lars Vedel Kessing: Epidemiology of mood disorders
68: Gin S. Malhi: Primary prevention of mood disorders: Building a
target for prevention strategies
Section 11: Bipolar disorder
69: Grant C. Churchill, Nisha Singh, and Michael J. Berridge: Basic
mechanisms of and treatment targets for bipolar disorder
70: Francis J. MacMahon and Sevilla Detera-Wadlieigh: Genetics of
bipolar disorder
71: Mary L. Phillips and Wayne C. Drevets: Neuroimaging of bipolar
disorder
72: Eduard Vieta, Isabella Pacchiarotti, and David J. Miklowitz:
Management and treatment of bipolar disorder
73: Ian Jones and Arianna Di Florio: Perinatal psychiatry
Section 12: Depressive disorders
74: Marcela Pereira, Roberto Andreatini, and Per Svenningsson:
Basic mechanisms of and treatment targets for depressive
disorders
75: Alison K. Merikangas and Kathleen R. Merikangas: Genetic
epidemiology of depression in the molecular era
76: Guy M. Goodwin and Michael Browning: Imaging of depressive
disorders
77: Philip J. Cowen: Management and treatment of depressive
disorders
Section 13: Trauma and stress or related and adjustment
disorders
78: Dean G. Kilpatrick, Matthew J. Friedman, and Amanda K. Gilmore:
Classification and descriptive psychopathology of posttraumatic
stress disorder and other stressor-related disorders
79: Bruce S. McEwen: Basic mechanisms of and treatment targets for
stress-related disorders
80: Michael G. Gottschalk and Katharina Domschke: Genetics of
stress-related disorders
81: Navneet Kaur, Cecilia Hinojosa, Julia Russell, Michael B. Van
Elzakker, and Lisa M. Shin: Imaging of stress-related disorders
82: Maria Bragesjö, Emily A. Holmes, Filip Arnberg, and Erik M.
Andersson: Primary prevention and epidemiology of trauma and stress
related disorders
83: Leigh van den Heuvel and Soraya Seedat: Management and
treatment of stress-related disorders
84: Beverley Raphael, Sally Wooding, and Julie Dunsmore:
Bereavement
85: Deborah Davis and Elizabeth F. Loftus: Recovered memories and
false memories
Section 14: Anxiety disorders
86: Nastassja Koen and Dan J. Stein: Core dimensions of anxiety
disorders
87: Martien Kas and Berend Olivier: Basic mechanisms, genetics,
targets and animal models for anxiety disorders
88: Hans-Ulrich Wittchen and Katja Beesdo-Baum: Epidemiology and
course of anxiety disorders
89: Michael G. Gottschalk and Katharina Domschke: Genetics of
anxiety disorders
90: Gregor Leicht and Christoph Mulert: Neuroimaging of anxiety
disorders
91: Aliza Werner-Seidler, Jennifer L. Hudson, and Helen
Christensen: The primary prevention of anxiety disorders
92: David S. Baldwin and Nathan T. M. Huneke: Treatment of anxiety
disorders
Section 15: Obsessive-compulsive and related disorders
93: Sophie C. Snyder, Eric A. Storch, and Wayne K. Goodman: Core
dimensions of obsessive-compulsive disorder
94: Eric Burguière and Luc Mallet: Basic mechanisms of and
treatment / planning targets for obsessive-complusive disorder
95: Lior Carmi, Naomi A. Fineberg, Oded Ben-Arush, and Joseph
Zohar: Obsessive-compulsive disorder
96: Gerald Nestadt and Jack Samuels: Genetics of
obsessive-compulsive disorder
97: Rebbia Shahab and Emily R. Stern: Imaging of
obsessive-compulsive disorder
98: Naomi A. Fineberg, Lynne M. Drummond, Jemma Reid, Eduardo
Cinosi, Lior Carmi, and Davis N. Mpavaenda: Management and
treatment of obsessive-compulsive disorder
99: Lorena Fernández de la Cruz and David Mataix-Cols: Hoarding
disorder
100: Megan M. Kelly and Katharine A. Phillips: Body dysmorphic
disorder
Section 16: Feeding and eating disorders
101: Chris Fairburn and Rebecca Murphy: The eating disorders
102: Johannes Hebebrand, Jochen Antel, and Beate Herpertz-Dahlmann:
Basic mechanisms and potential for treatment of weight and eating
disorders
103: Katherine A Halmi: Epidemiology and primary prevention of
feeding and eating disorders
104: Christopher Hüble, Cynthia Bulik, and Gerome Breen: Genetics
of feeding and eating disorders
105: Natalie Kurniadi, Christina E. Wierenga, Laura A. Berner, and
Walter H. Kaye: Imaging of feeding and eating disorders
106: Susan L. McElroy, Anna I. Guerdjikova, Nicole Mori, Paul L.
Houser, and Paul E. Keck, Jr.: Management and treatment of feeding
and eating disorders
107: Jamie Hartmann-Boyce, Nerys M. Astbury, and Susan A. Jebb:
Aetiology and management of obesity
108: Alexander von Gontard: Elimination disorders in children and
adolescents
Section 17: Sleep wake disorders
109: David Pritchett, Angus S. Fisk, Russell G. Foster, and Stuart
N. Peirson: Basic mechanisms of and treatment targets for
sleep-wake disorders
110: Kirstie Anderson: Diagnosis of sleep and circadian rhythm
disorder
111: Lena Katharina Keller, Eva C. Winnebeck, and Till Roenneberg:
Epidemiology of sleep-wake and primary prevention of its
disorders
112: Diego R. Mazzotti, Allan I. Pack, and Philip R. Gehrman:
Genetics of sleep-wake disorders
113: Umberto Moretto, Dylan Smith, Liliana Dell Osso, and Thien
Thanh Dang-Vu: Multi-modal imaging of sleep-wake disorders
114: Simon D. Kyle, Alasdair L. Henry, and Colin A. Espie:
Management of insomnia and circadian rhythm sleep-wake
disorders
Section 18: Sexual function and sexual dysfunction
115: Cynthia A. Graham and John Bancroft: The sexual dysfunctions
and paraphilias
116: Els Elaut and Gunter Heylens: Gender dysphoria
Section 19: Personality disorders
117: Andrew E. Skodol and Leslie C. Morey: Core dimensions of
personality pathology
118: Kate E. A. Saunders and Steve Pearce: Basic mechanisms of and
treatment planning / targets for personality disorders
119: Renato D. Alarcón and Brian A. Palmer: Personality disorders:
Epidemiology and clinical course
120: C. Robert Cloninger: Genetics of personality disorders
121: Christian Paret and Christian Schmahl: Imaging of personality
disorders
122: Giles Newton-Howes and Roger Mulder: Treatment and management
of personality disorder
Section 20: Impulse control and conduct disorders
123: Donald W. Black: Impulse control and its disorders: including
pathological gambling
124: Stephen Scott and Melanie Palmer: Conduct disorders and
antisocial personality disorder in childhood and adolescence
Section 21: Suicide
125: Merete Nordentoft, Trine Madsen, and Annette Erlangsen:
Epidemiology and causes of suicide
126: Nav Kapur, Sarah Steeg, and Adam Moreton: Self-harm:
Epidemiology and risk factors
127: J. John Mann and Dianne Currier: Biological aspects of
suicidal behaviour
128: Keith Hawton, Kate E. A. Saunders, and Alexandra Pitman:
Prevention of suicide and treatment following self-harm
Section 22: Somatic symptoms and related disorders
129: Michael Sharpe and Jane Walker: Deconstructing dualism: The
interface between physical and psychological illness
130: Chantal Berna and Irene Tracey: Neural mechanisms in chronic
pain relevant for psychiatric interventions
131: Jonathan Price: Treatment of fibromyalgia (chronic widespread
pain) and chronic fatigue syndrome
132: Thomas Merten and Harald Merckelbach: Factitious disorder and
malingering
133: Jon Stone and Michael Sharpe: Functional neurological symptom
disorder (Conversion disorder)
Section 23: Service provision
134: Martin Knapp: Public policy and service needs in mental
health
135: Tom Burns and Tony Kendrick: Planning and providing mental
health services for a community
136: Judit Simon: Health economic analysis of service provision
137: William H. Sledge and Julianne Dorset: The organization of
psychiatric services for general hospital departments: Proactive
and preventive interventions in psychiatry
138: Mina Fazel, Susan Rees, and Derrick Silove: Refugees and
populations exposed to mass conflict
Section 24: Forensic psychiatry
139: Seena Fazel and Mark Toynbee: Associations between psychiatric
disorder and offending
140: Sue Bailey and Prathiba Chitsabesan: Developmental approach to
understanding the needs of young people in contact with the
criminal justice system
141: Stephen J. Hucker: Child molesters and other sexual
offenders
142: Rosemary Purcell and Paul E. Mullen: Stalking and querulous
behaviour
143: Louise M. Howard and Deirdre MacManus: Domestic violence and
abuse and mental health
144: Alec Buchanan: Assessing and managing the risk of violence
towards others
145: John O Grady: The expert witness in the criminal and civil
courts
146: Matthew Large and Olav Nielssen: Homicide
John R. Geddes is Professor of Epidemiological Psychiatry and Head of the Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK. Nancy C. Andreasen is Professor of Psychiatry and Andrew H. Woods Chair of Psychiatry, Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USA. Guy M. Goodwin is Senior Research Fellow, Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
Much gratitude is due to the distinguished editors for bringing us
the book, the many first-class authors for contributing their
chapters and Oxford University Press for their excellent
production. The book will, in my view, continue to occupy a
dominant place in the international medical literature and, at
least for the foreseeable future, could well turn out to be the
most widely used and influential reference work of its kind in
psychiatry.
*J Guy Edwards, FRCPsych, FRCP, FRCGP(Hon), HonMFPH, DPM, Retired
Consultant Psychiatrist, UK, Medico-Legal Journal*
![]() |
Ask a Question About this Product More... |
![]() |